DUSP18: Potential Drug Targets and Biomarkers for Alzheimer's, Parkinson's and Colorectal Cancer

Target Name: DUSP18

NCBI ID: G150290

DUSP18

DUSP18: Potential Drug Targets and Biomarkers for Alzheimer's, Parkinson's and Colorectal Cancer

DUSP18 (doublecortin-related protein 18) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the doublecortin family of proteins, which are characterized by the presence of a doublecortin domain and a distinct N-terminus. The doublecortin family is thought to play a role in various physiological processes, including stress response, neurodegeneration, and cancer.

Recent studies have identified DUSP18 as a potential drug target or biomarker for various diseases, including Alzheimer's disease, Parkinson's disease, and colorectal cancer. This has led to increased interest in the characterization of DUSP18 and its potential role in these diseases.

DUSP18 function and localization

DUSP18 is a 16-kDa protein that is expressed in the brain, pancreas, and gastrointestinal tract. It is predominantly expressed in the brain, with lower levels detected in the pancreas and gastrointestinal tract. DUSP18 is localized to the endoplasmic reticulum (ER) and the trans-endoplasmic reticulum (TER), which are specialized structures that play important roles in the regulation of protein synthesis and degradation.

DUSP18 functions as a protein that is involved in various cellular processes, including stress response, neurodegeneration, and cancer. It is thought to function as a negative regulator of the stress response pathway, which is involved in the regulation of protein synthesis and degradation in response to stress. DUSP18 is also involved in the regulation of cell survival and apoptosis, as well as in the development and progression of cancer.

DUSP18 as a drug target

DUSP18 has been identified as a potential drug target for a variety of diseases, including Alzheimer's disease, Parkinson's disease, and colorectal cancer. This is based on the fact that DUSP18 is involved in the regulation of various cellular processes that are implicated in the development and progression of these diseases.

In Alzheimer's disease, DUSP18 has been shown to be involved in the regulation of neurodegeneration and the development of neurofibrillary tangles, which are thought to contribute to the progressive neurodegeneration that is observed in this disease. In addition, DUSP18 has been shown to be involved in the regulation of the stress response pathway, which is thought to play a role in the development of neurodegeneration in response to stress.

In Parkinson's disease, DUSP18 has been shown to be involved in the regulation of the neurotransmitter dopamine, which is thought to play a role in the regulation of movement and motor behavior. In addition, DUSP18 has been shown to be involved in the regulation of the stress response pathway, which is thought to play a role in the development of neurodegeneration in response to stress.

In colorectal cancer, DUSP18 has been shown to be involved in the regulation of the growth and survival of cancer cells. This is thought to contribute to the development and progression of colorectal cancer.

DUSP18 as a biomarker

DUSP18 has also been identified as a potential biomarker for various diseases, including Alzheimer's disease, Parkinson's disease, and colorectal cancer. This is based on the fact that DUSP18 is expressed in these diseases and has been shown to be involved in the regulation of various cellular processes that are implicated in the development and progression of these diseases.

In Alzheimer's disease, DUSP18 has been shown to be involved in the regulation of neurodegeneration and the development of neurofibrillary tangles, which are thought to contribute to the progressive neurodegeneration that is observed in this disease. In addition, DUSP18 has been shown to be involved in the regulation of the stress response pathway, which is thought to play a role in the development of neurodegeneration in response to stress.

In Parkinson's disease, DUSP18 has been shown to be involved in the regulation of the neurotransmitter dopamine, which is thought to play a role in the regulation of movement and motor behavior. In addition, DUSP18 has been shown to be involved in the regulation of the stress response pathway, which is thought to play a role in the development of neurodegeneration in response to stress.

In colorectal cancer, DUSP18 has been shown to be involved in the regulation of the growth and survival of cancer cells. This is thought to contribute to the development and progression of colorectal cancer.

Conclusion

DUSP18 is a protein that is expressed in various tissues of the body and is involved in various cellular processes that are important for the regulation of protein synthesis and degradation, stress response, neurodegeneration, and cancer. As a result, DUSP18 has been identified as a potential drug target or biomarker for a variety of diseases, including Alzheimer's disease, Parkinson's disease, and colorectal cancer. Further research is needed to fully understand the role of DUSP18 in these diseases and to develop effective treatments.

Protein Name: Dual Specificity Phosphatase 18

Functions: Can dephosphorylate single and diphosphorylated synthetic MAPK peptides, with preference for the phosphotyrosine and diphosphorylated forms over phosphothreonine. In vitro, dephosphorylates p-nitrophenyl phosphate (pNPP)

The "DUSP18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets